IMMUNE-MEDIATED CHOLESTASIS

IMMUNE-MEDIATED CHOLESTASIS was reported 37 times

IMMUNE-MEDIATED CHOLESTASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Lymphocyte Activation Gene-3 Blocker [EPC] 1 0.0019
1 Programmed Death Receptor-1 Blocking Antibody [EPC] 33 0.0003
2 Substance P/Neurokinin-1 Receptor Antagonist [EPC] 2 0.0002
3 CTLA-4-directed Blocking Antibody [EPC] 5 0.0001
4 Programmed Death Ligand-1 Blocker [EPC] 1 0.0000
5 Bile Acid [EPC] 1 0.0000
6 Microtubule Inhibitor [EPC] 6 0.0000
7 Platinum-based Drug [EPC] 9 0.0000
8 Erythropoiesis-stimulating Agent [EPC] 1 0.0000
9 Serotonin-3 Receptor Antagonist [EPC] 2 0.0000
10 Leukocyte Growth Factor [EPC] 2 0.0000
11 Histamine-1 Receptor Antagonist [EPC] 1 0.0000
12 Osmotic Laxative [EPC] 3 0.0000
13 Alkylating Drug [EPC] 2 0.0000
14 Phosphodiesterase 5 Inhibitor [EPC] 1 0.0000
15 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
16 Azole Antifungal [EPC] 1 0.0000
17 Dihydropyridine Calcium Channel Blocker [EPC] 2 0.0000
18 Proton Pump Inhibitor [EPC] 3 0.0000
19 Mood Stabilizer [EPC] 1 0.0000
20 Anti-epileptic Agent [EPC] 1 0.0000
21 Atypical Antipsychotic [EPC] 2 0.0000
22 Loop Diuretic [EPC] 2 0.0000
23 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
24 Vitamin D [EPC] 1 0.0000
25 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
26 Vitamin B12 [EPC] 1 0.0000
27 Vitamin C [EPC] 1 0.0000
28 Insulin Analog [EPC] 1 0.0000
29 Kinase Inhibitor [EPC] 1 0.0000
30 Platelet Aggregation Inhibitor [EPC] 1 0.0000
31 Corticosteroid [EPC] 2 0.0000
32 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
33 Benzodiazepine [EPC] 1 0.0000